Quantitative EEG as a predictive biomarker for Parkinson disease dementia

Objective: We evaluated quantitative EEG (QEEG) measures as predictive biomarkers for the development of dementia in Parkinson disease (PD). Preliminary work shows that QEEG measures correlate with current PD cognitive state. A reliable predictive QEEG biomarker for PD dementia (PD-D) incidence would be valuable for studying PD-D, including treatment trials aimed at preventing cognitive decline in PD. Methods: A cohort of subjects with PD in our brain donation program utilizes annual premortem longitudinal movement and cognitive evaluation. These subjects also undergo biennial EEG recording. EEG from subjects with PD without dementia with follow-up cognitive evaluation was analyzed for QEEG measures of background rhythm frequency and relative power in δ, θ, α, and β bands. The relationship between the time to onset of dementia and QEEG and other possible predictors was assessed by using Cox regression. Results: The hazard of developing dementia was 13 times higher for those with low background rhythm frequency (lower than the grand median of 8.5 Hz) than for those with high background rhythm frequency (p < 0.001). Hazard ratios (HRs) were also significant for > median θ bandpower (HR = 3.0; p = 0.004) compared to below, and for certain neuropsychological measures. The HRs for δ, α, and β bandpower as well as baseline demographic and clinical characteristics were not significant. Conclusion: The QEEG measures of background rhythm frequency and relative power in the θ band are potential predictive biomarkers for dementia incidence in PD. These QEEG biomarkers may be useful in complementing neuropsychological testing for studying PD-D incidence.

[1]  C. Adler,et al.  Motor impairment in normal aging, clinically possible Parkinson's disease, and clinically probable Parkinson's disease: longitudinal evaluation of a cohort of prospective brain donors. , 2002, Parkinsonism & related disorders.

[2]  W. Ray,et al.  EEG alpha activity reflects attentional demands, and beta activity reflects emotional and cognitive processes. , 1985, Science.

[3]  K. Jellinger.  The association of incident dementia with mortality in PD , 2003, Neurology.

[4]  G. Stebbins,et al.  Risk factors for nursing home placement in advanced Parkinson's disease , 1993, Neurology.

[5]  G. Halliday,et al.  The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.

[6]  H. Shill,et al.  Defining mild cognitive impairment in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[7]  A. Lees,et al.  What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.

[8]  Ken Kelley,et al.  A Best Practice for Research , 2007 .

[9]  E. Londos,et al.  Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial , 2009, The Lancet Neurology.

[10]  D. Matthews,et al.  Children with Type 2 Diabetes: The Risks of Complications , 2002, Hormone Research in Paediatrics.

[11]  F. L. D. Silva,et al.  Basic mechanisms of cerebral rhythmic activities , 1990 .

[12]  Günther Deuschl,et al.  Rivastigmine for dementia associated with Parkinson's disease. , 2004, The New England journal of medicine.

[13]  R. Barry,et al.  A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography , 2003, Clinical Neurophysiology.

[14]  G. Tedrus,et al.  Dementia, Mild Cognitive Impairment and Quantitative EEG in Patients with Parkinson's Disease , 2009, Clinical EEG and neuroscience.

[15]  T. Pedley,et al.  Beta and Mu Rhythms , 1990, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[16]  A. Morita,et al.  Comparison of Quantitative EEGs Between Parkinson Disease and Age-Adjusted Normal Controls , 2008, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[17]  W. Poewe,et al.  Long‐term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[18]  A. Korczyn,et al.  EEG in demented and non‐demented parkinsonian patients , 1988, Acta neurologica Scandinavica.

[19]  T. Gasser,et al.  Test-retest reliability of spectral parameters of the EEG. , 1985, Electroencephalography and clinical neurophysiology.

[20]  D. Aarsland,et al.  The epidemiology of dementia associated with Parkinson disease , 2010, Journal of the Neurological Sciences.

[21]  I. Mézan,et al.  EEG findings in Parkinsonism. , 1963, Electroencephalography and clinical neurophysiology.

[22]  Keith A. Johnson,et al.  Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.

[23]  H. Soininen,et al.  Slowing of EEG in Parkinson's disease. , 1991, Electroencephalography and clinical neurophysiology.

[24]  G. Broe,et al.  A longitudinal of Parkinson's disease: clinical and neuropsychological correlates of dementia , 1996, Journal of Clinical Neuroscience.

[25]  B. Oken,et al.  Test-retest reliability in EEG frequency analysis. , 1991, Electroencephalography and clinical neurophysiology.

[26]  Y. Parmet,et al.  EEG frequency analysis in demented and nondemented parkinsonian patients. , 1994, Dementia.

[27]  Yoshitaka Fuwamoto,et al.  Analysis of music–brain interaction with simultaneous measurement of regional cerebral blood flow and electroencephalogram beta rhythm in human subjects , 1999, Neuroscience Letters.

[28]  P. Tonner,et al.  Altered states of consciousness: processed EEG in mental disease. , 2006, Best practice & research. Clinical anaesthesiology.

[29]  M. Holtmann,et al.  Role of electroencephalography in attention-deficit hyperactivity disorder , 2006, Expert review of neurotherapeutics.

[30]  C. Adler,et al.  Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease. , 2007, Parkinsonism & related disorders.

[31]  Helmut Laufs,et al.  Endogenous brain oscillations and related networks detected by surface EEG‐combined fMRI , 2008, Human brain mapping.